Significance of molecular karyotyping for diagnosis specification in case of cytogenetically detected chromosomal aberrations
https://doi.org/10.1234/XXXX-XXXX-2016-7-17-20
Abstract
About the Authors
E. O. BelyaevaRussian Federation
A. A. Kashevarova
Russian Federation
A. M. Nikonov
Russian Federation
O. V. Plotnikova
Russian Federation
N. A. Skryabin
Russian Federation
L. P. Nazarenko
Russian Federation
I. N. Lebedev
Russian Federation
References
1. Kolevzon A, Angarita B, Bush L et al. Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring. J Neurodev Disord. 2014; 6(1):39.
2. Luciani JJ, de Mas P, Depetris D et al. Telomeric 22q13 deletions resulting from rings, simple deletions, and translocations: cytogenetic, molecular, and clinical analyses of 32 new observations. J Med Genet. 2003; 40(9):690-696.
3. Vuillaume ML, Delrue MA, Naudion S et al. Expanding the clinical phenotype at the 3q13. 31 locus with a new case of microdeletion and first characterization of the reciprocal duplication. Mol Genet Metab. 2013; 110(1-2):90-97.
4. Molin AM, Andrieux J, Koolen DA et al. A novel microdeletion syndrome at 3q13.31 characterised by developmental delay, postnatal overgrowth, hypoplastic male genitals, and characteristic facial features. J Med Genet. 2011; 49(2):104-109.
Review
For citations:
Belyaeva E.O., Kashevarova A.A., Nikonov A.M., Plotnikova O.V., Skryabin N.A., Nazarenko L.P., Lebedev I.N. Significance of molecular karyotyping for diagnosis specification in case of cytogenetically detected chromosomal aberrations. Medical Genetics. 2016;15(7):17-20. (In Russ.) https://doi.org/10.1234/XXXX-XXXX-2016-7-17-20